Opiant Pharmaceuticals is a pharmaceutical company developing medicines for addictions and drug overdose. Co.'s longer term pipeline includes medicines in development for Alcohol Use Disorder, Opioid Use Disorder, and Acute Cannabinoid Overdose. Co. is also pursuing other treatment opportunities within the addiction and drug overdose field. Co. has developed NARCAN® (naloxone hydrochloride) Nasal Spray, a treatment to reverse opioid overdose. We show 33 historical shares outstanding datapoints in our OPNT shares outstanding history coverage, used to compute OPNT market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing OPNT market cap history over the course of time is important for investors
interested in comparing OPNT's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of OPNT versus a peer is one thing; comparing
OPNT market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like OPNT can fluctuate over the course of history.
With this page we aim to empower investors researching OPNT by allowing them to research the OPNT market cap history. |
Free OPNT Email Alerts:
Video: The Importance of Market Cap
